Human WT1(Wilms Tumor Protein) ELISA Kit
To Order Contact us: Lara@lipidx.org
 ELISA Kit) Human Wilms Tumor Protein (WT1) ELISA Kit |
|
SEF116Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5677.8 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Wilms Tumor Protein (WT1) in tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
SEF116Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 572.76 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Wilms Tumor Protein (WT1) in tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
SEF116Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 766.8 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Wilms Tumor Protein (WT1) in tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
SEF116Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3090.6 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Wilms Tumor Protein (WT1) in tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
4-SEF116Hu |
Cloud-Clone |
-
EUR 5738.40
-
EUR 3031.20
-
EUR 768.00
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Wilms Tumor Protein (WT1) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
RD-WT1-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 625.2 |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
RD-WT1-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 867.6 |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
RDR-WT1-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 652.8 |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
RDR-WT1-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 907.2 |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
RDR-WT1-Hu-48T |
Reddot Biotech |
48T |
EUR 475.34 |
|
|
|
Description: tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
RDR-WT1-Hu-96T |
Reddot Biotech |
96T |
EUR 679.04 |
|
|
|
Description: tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
RD-WT1-Hu-48T |
Reddot Biotech |
48T |
EUR 452.7 |
|
|
|
Description: tissue homogenates, cell lysates and other biological fluids. |
Human Wilms Tumor Protein (WT1) ELISA Kit |
|
RD-WT1-Hu-96T |
Reddot Biotech |
96T |
EUR 646.7 |
|
|
|
Description: tissue homogenates, cell lysates and other biological fluids. |
) ELISA kit for Human WT1 (Wilms Tumor Protein) |
|
ELK3382 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
|
|
Description: A sandwich ELISA kit for detection of Wilms Tumor Protein from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
) ELISA kit for Human Wilms tumor protein (WT1) |
|
KTE60017-48T |
Abbkine |
48T |
EUR 398.4 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Wilms tumor protein (WT1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Wilms tumor protein (WT1) |
|
KTE60017-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2538 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Wilms tumor protein (WT1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Wilms tumor protein (WT1) |
|
KTE60017-96T |
Abbkine |
96T |
EUR 646.8 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Wilms tumor protein (WT1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
) Human Wilms tumor protein (WT1) |
|
1-CSB-RP116094h |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Human Wilms tumor protein(WT1),partial expressed in E.coli |
Human Wilms tumor protein (WT1) |
|
1-CSB-YP026158HU |
Cusabio |
-
EUR 516.00
-
EUR 280.80
-
EUR 1809.60
-
EUR 770.40
-
EUR 1210.80
-
EUR 349.20
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Human Wilms tumor protein(WT1) expressed in Yeast |
Human Wilms tumor protein (WT1) |
|
1-CSB-EP026158HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Human Wilms tumor protein(WT1) expressed in E.coli |
 Rat Wt1/ Wilms tumor protein homolog ELISA Kit |
|
E1039Ra |
Sunlong |
1 Kit |
EUR 775.2 |
CLIA Kit) Human Wilms Tumor Protein (WT1)CLIA Kit |
|
SCF116Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 6777.36 |
|
|
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1) in Tissue homogenates and other biological fluids. |
Human Wilms Tumor Protein (WT1)CLIA Kit |
|
SCF116Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 663.31 |
|
|
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1) in Tissue homogenates and other biological fluids. |
Human Wilms Tumor Protein (WT1)CLIA Kit |
|
SCF116Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 896.16 |
|
|
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1) in Tissue homogenates and other biological fluids. |
Human Wilms Tumor Protein (WT1)CLIA Kit |
|
SCF116Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3672.72 |
|
|
|
Description: This is Double-antibody Sandwich Chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1) in Tissue homogenates and other biological fluids. |
 CLIA Kit) Human Wilms Tumor Protein (WT1) CLIA Kit |
|
4-SCF116Hu |
Cloud-Clone |
-
EUR 6837.60
-
EUR 3673.20
-
EUR 896.40
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Double-antibody Sandwich chemiluminescent immunoassay for detection of Human Wilms Tumor Protein (WT1)Tissue homogenates and other biological fluids |
 Mouse Wt1/ Wilms tumor protein homolog ELISA Kit |
|
E1600Mo |
Sunlong |
1 Kit |
EUR 758.4 |
 Wt1 ELISA Kit| Rat Wilms tumor protein ELISA Kit |
|
EF019480 |
Lifescience Market |
96 Tests |
EUR 826.8 |
 Wt1 ELISA Kit| Mouse Wilms tumor protein ELISA Kit |
|
EF016508 |
Lifescience Market |
96 Tests |
EUR 826.8 |
 Protein) Human Wilms Tumor 1 (WT1) Protein |
|
20-abx650641 |
Abbexa |
-
EUR 510.00
-
EUR 276.00
-
EUR 1378.80
-
EUR 594.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Mouse Wilms tumor protein homolog, Wt1 ELISA KIT |
|
ELI-40533m |
Lifescience Market |
96 Tests |
EUR 1038 |
 ELISA Kit) Human Wilms Tumor 1 (WT1) ELISA Kit |
|
abx570884-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
|
Human Wilms Tumor 1 (WT1) ELISA Kit |
|
20-abx153501 |
Abbexa |
-
EUR 8853.60
-
EUR 4719.60
-
EUR 1093.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
 Porcine Wilms tumor protein homolog, WT1 ELISA KIT |
|
ELI-17852p |
Lifescience Market |
96 Tests |
EUR 1113.6 |
 Antibody) Wilms Tumor Protein (WT1) Antibody |
|
20-abx175128 |
Abbexa |
|
|
|
|
Wilms Tumor Protein (WT1) Antibody |
|
20-abx178910 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Wilms Tumor Protein (WT1) Antibody |
|
20-abx178911 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1562.40
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Wilms Tumor Protein (WT1) Antibody |
|
20-abx178912 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1562.40
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Wilms Tumor Protein (WT1) Antibody |
|
20-abx131682 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1446.00
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
) WT1 Antibody (Wilms Tumor protein) |
|
F41819-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: Wilms Tumor protein is a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilm's tumors. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation site upstream of and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq]. |
WT1 Antibody (Wilms Tumor protein) |
|
F41819-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: Wilms Tumor protein is a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilm's tumors. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation site upstream of and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq]. |
) Recombinant Wilms Tumor Protein (WT1) |
|
4-RPF116Hu01 |
Cloud-Clone |
-
EUR 356.54
-
EUR 218.40
-
EUR 1007.04
-
EUR 415.68
-
EUR 711.36
-
EUR 314.40
-
EUR 2337.60
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Wilms Tumor Protein expressed in: E.coli |
Recombinant Wilms Tumor Protein (WT1) |
|
4-RPF116Hu02 |
Cloud-Clone |
-
EUR 356.54
-
EUR 218.40
-
EUR 1007.04
-
EUR 415.68
-
EUR 711.36
-
EUR 314.40
-
EUR 2337.60
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Wilms Tumor Protein expressed in: E.coli |
 Protein (OVA)) Human Wilms Tumor 1 (WT1) Protein (OVA) |
|
20-abx651868 |
Abbexa |
-
EUR 678.00
-
EUR 309.60
-
EUR 1963.20
-
EUR 794.40
-
EUR 493.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Polyclonal Antibody (Human)) Wilms Tumor Protein (WT1) Polyclonal Antibody (Human) |
|
4-PAF116Hu01 |
Cloud-Clone |
-
EUR 296.40
-
EUR 3012.00
-
EUR 750.00
-
EUR 372.00
-
EUR 256.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1) |
) OVA Conjugated Wilms Tumor Protein (WT1) |
|
4-CPF116Hu21 |
Cloud-Clone |
-
EUR 474.82
-
EUR 250.80
-
EUR 1450.56
-
EUR 563.52
-
EUR 1007.04
-
EUR 393.60
-
EUR 3446.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Wilms Tumor Protein expressed in: Protein conjugation |
OVA Conjugated Wilms Tumor Protein (WT1) |
|
4-CPF116Mu21 |
Cloud-Clone |
-
EUR 474.82
-
EUR 250.80
-
EUR 1450.56
-
EUR 563.52
-
EUR 1007.04
-
EUR 393.60
-
EUR 3446.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Mouse Wilms Tumor Protein expressed in: Protein conjugation |
OVA Conjugated Wilms Tumor Protein (WT1) |
|
4-CPF116Ra21 |
Cloud-Clone |
-
EUR 474.82
-
EUR 250.80
-
EUR 1450.56
-
EUR 563.52
-
EUR 1007.04
-
EUR 393.60
-
EUR 3446.40
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Rat Wilms Tumor Protein expressed in: Protein conjugation |
 ELISA Kit) Pig Wilms Tumor 1 (WT1) ELISA Kit |
|
abx515509-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
|
 ELISA Kit) Rat Wilms Tumor 1 (WT1) ELISA Kit |
|
abx515510-96tests |
Abbexa |
96 tests |
EUR 886.8 |
|
|
 ELISA Kit) Mouse Wilms Tumor 1 (WT1) ELISA Kit |
|
abx515508-96tests |
Abbexa |
96 tests |
EUR 886.8 |
|
|
 Polyclonal Antibody (Human), PE) Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), PE |
|
4-PAF116Hu01-PE |
Cloud-Clone |
-
EUR 355.20
-
EUR 3168.00
-
EUR 900.00
-
EUR 446.40
-
EUR 234.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with PE. |
 Polyclonal Antibody (Human), APC) Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), APC |
|
4-PAF116Hu01-APC |
Cloud-Clone |
-
EUR 414.00
-
EUR 3930.00
-
EUR 1094.40
-
EUR 528.00
-
EUR 262.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with APC. |
 Polyclonal Antibody (Human), Cy3) Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), Cy3 |
|
4-PAF116Hu01-Cy3 |
Cloud-Clone |
-
EUR 502.80
-
EUR 5190.00
-
EUR 1410.00
-
EUR 654.00
-
EUR 301.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with Cy3. |
 Polyclonal Antibody (Human), HRP) Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), HRP |
|
4-PAF116Hu01-HRP |
Cloud-Clone |
-
EUR 379.20
-
EUR 3426.00
-
EUR 968.40
-
EUR 477.60
-
EUR 247.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with HRP. |
 Polyclonal Antibody (Human), FITC) Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), FITC |
|
4-PAF116Hu01-FITC |
Cloud-Clone |
-
EUR 355.20
-
EUR 3168.00
-
EUR 900.00
-
EUR 446.40
-
EUR 234.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with FITC. |
 CLIA Kit) Human Wilms Tumor 1 (WT1) CLIA Kit |
|
20-abx190177 |
Abbexa |
-
EUR 9493.20
-
EUR 5058.00
-
EUR 1167.60
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
 Protein (OVA)) Rat Wilms Tumor 1 (WT1) Protein (OVA) |
|
20-abx651870 |
Abbexa |
-
EUR 678.00
-
EUR 309.60
-
EUR 1963.20
-
EUR 794.40
-
EUR 493.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein (OVA)) Mouse Wilms Tumor 1 (WT1) Protein (OVA) |
|
20-abx651869 |
Abbexa |
-
EUR 678.00
-
EUR 309.60
-
EUR 1963.20
-
EUR 794.40
-
EUR 493.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Polyclonal Antibody (Human), Biotinylated) Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), Biotinylated |
|
4-PAF116Hu01-Biotin |
Cloud-Clone |
-
EUR 373.20
-
EUR 2952.00
-
EUR 872.40
-
EUR 457.20
-
EUR 262.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with Biotin. |
 Polyclonal Antibody (Human), APC-Cy7) Wilms Tumor Protein (WT1) Polyclonal Antibody (Human), APC-Cy7 |
|
4-PAF116Hu01-APC-Cy7 |
Cloud-Clone |
-
EUR 685.20
-
EUR 7716.00
-
EUR 2046.00
-
EUR 912.00
-
EUR 382.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Wilms Tumor Protein (WT1). This antibody is labeled with APC-Cy7. |
 ELISA kit for Human Wilms tumor protein |
|
EK2852 |
SAB |
96 tests |
EUR 663.6 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Wilms tumor protein in samples from serum, plasma, tissue homogenates and other biological fluids. |
 Antibody) Wilms Tumor 1 (WT1) Antibody |
|
abx239528-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
|
Wilms Tumor 1 (WT1) Antibody |
|
abx224107-100ug |
Abbexa |
100 ug |
EUR 493.2 |
|
|
Wilms Tumor 1 (WT1) Antibody |
|
abx215781-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
|
Wilms Tumor 1 (WT1) Antibody |
|
20-abx116670 |
Abbexa |
|
|
|
|
Wilms Tumor 1 (WT1) Antibody |
|
20-abx334134 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Wilms Tumor 1 (WT1) Antibody |
|
abx430953-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
|
Wilms Tumor 1 (WT1) Antibody |
|
20-abx001111 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Wilms Tumor 1 (WT1) Antibody |
|
20-abx142313 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 376.80
|
|
|
|
 WT1 Antibody / Wilms Tumor 1 |
|
V3610-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V3610-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V3610IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V3610SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V8926-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
|
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. |
WT1 Antibody / Wilms Tumor 1 |
|
V8926-20UG |
NSJ Bioreagents |
20ug |
EUR 153.3 |
|
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. |
WT1 Antibody / Wilms Tumor 1 |
|
V8926SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
|
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. |
WT1 Antibody / Wilms Tumor 1 |
|
V9173-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
|
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. In tumor tissues, WT1 is detected in tumor cells of Wilms Tumor (also known as nephroblastoma) and mesothelioma. Additionally, WT1 expression has been found in ovarian serous carcinomas and some breast carcinomas. WT1 is particularly used for distinguishing malignant mesothelioma and ovarian serous carcinoma from non-serous carcinomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V9173-20UG |
NSJ Bioreagents |
20ug |
EUR 153.3 |
|
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. In tumor tissues, WT1 is detected in tumor cells of Wilms Tumor (also known as nephroblastoma) and mesothelioma. Additionally, WT1 expression has been found in ovarian serous carcinomas and some breast carcinomas. WT1 is particularly used for distinguishing malignant mesothelioma and ovarian serous carcinoma from non-serous carcinomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V9173SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 349.3 |
|
Description: The WT1 gene located at chromosome 11p13 codes for a transcription factor, a DNA-binding nucleoprotein, that plays a role primarily in the development of genitourinary organs. There are at least eight isoforms ranging between 52 and 62kDa produced by a combination of alternative splicing and RNA editing. WT1 is synthesized and reside in the cytoplasm in an inactive form. When activated through phosphorylation it is translocated to the nucleus. In tumor tissues, WT1 is detected in tumor cells of Wilms Tumor (also known as nephroblastoma) and mesothelioma. Additionally, WT1 expression has been found in ovarian serous carcinomas and some breast carcinomas. WT1 is particularly used for distinguishing malignant mesothelioma and ovarian serous carcinoma from non-serous carcinomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V7164-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
|
V7164-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
|
V7164IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
|
V7164SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
|
V7205-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V7205-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V7205IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V7205SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V7263-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V7263-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V7263IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V7263SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Wilms tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2930-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2930-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2930IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2930SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2931-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2931-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2931IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2931SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2932-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2932-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2932IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V2932SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V7601-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
|
V7601-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
|
V7601IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
|
V7601SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Wilms Tumor is a transcription factor that plays an important role in cellular development and cell survival. Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. Recognizes and binds to the DNA sequence 5'-CGCCCCCGC-3'. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may act as transcription factors. Isoforms containing the KTS motif may bind mRNA and play a role in mRNA metabolism or splicing. Isoform 1 has lower affinity for DNA, and can bind RNA. [UniProt] |
WT1 Antibody / Wilms Tumor 1 |
|
V8166-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V8166-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody / Wilms Tumor 1 |
|
V8166SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilms tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
 Antibody (HRP)) Wilms Tumor 1 (WT1) Antibody (HRP) |
|
20-abx338311 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody Pair) Wilms Tumor 1 (WT1) Antibody Pair |
|
abx117613-1pair5x96wellplates |
Abbexa |
1 pair (5x96 well plates) |
EUR 1212 |
|
|
 Antibody (FITC)) Wilms Tumor 1 (WT1) Antibody (FITC) |
|
20-abx338312 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (Biotin)) Wilms Tumor 1 (WT1) Antibody (Biotin) |
|
20-abx338313 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 WT1 Antibody Cocktail / Wilms Tumor 1 |
|
V2933-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody Cocktail / Wilms Tumor 1 |
|
V2933-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody Cocktail / Wilms Tumor 1 |
|
V2933IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
WT1 Antibody Cocktail / Wilms Tumor 1 |
|
V2933SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: Recognizes a 47-55kDa-tumor suppressor protein, identified as Wilm's Tumor (WT1) protein. The antibody reacts with all isoforms of the full-length WT1 and also identifies WT1 lacking exon 2-encoded amino acids, frequently found in subsets of sporadic Wilm s tumors. WT1, a sporadic and familial pediatric kidney tumor, is genetically heterogeneous. Wilm s tumor is associated with mutations of WT1, a zinc-finger transcription factor that is essential for the development of the metanephric kidney and the urogenital system. The WT1 gene is normally expressed in fetal kidney and mesothelium, and its expression has been suggested as a marker for Wilm s tumor and mesothelioma. WT1 protein has been identified in proliferative mesothelial cells, malignant mesothelioma, ovarian carcinoma, gonadoblastoma, nephroblastoma, and desmoplastic small round cell tumor. Lung adenocarcinomas rarely stain positive with this antibody. WT1 protein expression in mesothelial cells has become a reliable marker for the diagnosis of mesotheliomas. |
 ELISA Kit) Human WTIP(Wilms tumor protein 1-interacting protein) ELISA Kit |
|
EH2071 |
FN Test |
96T |
EUR 681.12 |
|
|
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 46.9pg/ml |
 Human WTIP/ Wilms tumor protein 1-interacting protein ELISA Kit |
|
E2698Hu |
Sunlong |
1 Kit |
EUR 685.2 |
 Human Wilms tumor protein 1- interacting protein, WTIP ELISA KIT |
|
ELI-06581h |
Lifescience Market |
96 Tests |
EUR 988.8 |
 ELISA Kit) Human Wilms tumor protein 1-interacting protein (WTIP) ELISA Kit |
|
abx251402-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
|
ELISA kit) Human Wilms tumor protein 1-interacting protein(WTIP)ELISA kit |
|
YLA4432HU-48T |
Shanghai YL Biotech |
48T |
EUR 435 |
Human Wilms tumor protein 1-interacting protein(WTIP)ELISA kit |
|
YLA4432HU-96T |
Shanghai YL Biotech |
96T |
EUR 562.5 |
 ELISA kit for Mouse Wilms tumor protein homolog |
|
EK2851 |
SAB |
96 tests |
EUR 804 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse Wilms tumor protein homolog in samples from serum, plasma, tissue homogenates and other biological fluids. |
) Polyclonal WT1 / Wilms Tumor 1 Antibody (C-Terminus) |
|
APR02352G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human WT1 / Wilms Tumor 1 (C-Terminus). This antibody is tested and proven to work in the following applications: |
 Wilms Tumor Protein Antibody |
|
48959-100ul |
SAB |
100ul |
EUR 399.6 |
Wilms Tumor Protein Antibody |
|
48959-50ul |
SAB |
50ul |
EUR 286.8 |
 Mouse Wilms tumor protein 1- interacting protein, Wtip ELISA KIT |
|
ELI-06580m |
Lifescience Market |
96 Tests |
EUR 1038 |
 ELISA Kit) Mouse Wilms tumor protein 1-interacting protein (WTIP) ELISA Kit |
|
abx519242-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
|
